Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS-Reference-Cited by-同舟云学术

Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS

Published:2019-06-21 Issue:9 Volume:33 Page:2254-2265
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Knecht Henrik, ,Reigl Tomas,Kotrová Michaela^ORCID,Appelt Franziska,Stewart Peter,Bystry Vojtech,Krejci Adam,Grioni Andrea,Pal Karol,Stranska Kamila,Plevova Karla,Rijntjes Jos,Songia Simona,Svatoň Michael,Froňková Eva,Bartram Jack,Scheijen Blanca,Herrmann Dietrich,García-Sanz Ramón^ORCID,Hancock Jeremy,Moppett John^ORCID,van Dongen Jacques J. M.,Cazzaniga Giovanni^ORCID,Davi Frédéric,Groenen Patricia J. T. A.,Hummel Michael,Macintyre Elizabeth A.,Stamatopoulos Kostas,Trka Jan,Langerak Anton W.,Gonzalez David,Pott Christiane,Brüggemann Monika,Darzentas Nikos

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-019-0499-4.pdf

Reference29 articles.

1. Pott C. Minimal residual disease detection in mantle cell lymphoma: technical aspects and clinical relevance. Semin Hematol. 2011;48:172–84.

2. Ferrero S, Drandi D, Mantoan B, Ghione P, Omedè P, Ladetto M. Minimal residual disease detection in lymphoma and multiple myeloma: Impact on therapeutic paradigms. Hematol Oncol. 2011;29:167–76.

3. Brüggemann M, Gökbuget N, Kneba M. Acute lymphoblastic leukemia: monitoring minimal residual disease as a therapeutic principle. Semin Oncol. 2012;39:47–57.

4. Brüggemann M, Raff T, Kneba M. Has MRD monitoring superseded other prognostic factors in adult ALL? Blood. 2012;120:4470–81.

5. Van Dongen JJM, Seriu T, Panzer-Grümayer ER, Biondi A, Pongers-Willemse MJ, Corral L, et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet. 1998;352:1731–8.

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring measurable residual disease in paediatric acute lymphoblastic leukaemia using immunoglobulin gene clonality based on next-generation sequencing;Cancer Cell International;2024-06-25

2. Liquid biopsy for molecular characterization of diffuse large B‐cell lymphoma and early assessment of minimal residual disease;British Journal of Haematology;2024-05-29

3. Molecular Screening in Anaplastic Lymphoma Kinase–Positive Anaplastic Large Cell Lymphoma: Anaplastic Lymphoma Kinase Analysis, Next-Generation Sequencing Fusion Gene Detection, and T-Cell Receptor Immunoprofiling;Modern Pathology;2024-03

4. Adaptive immune receptor repertoire analysis;Nature Reviews Methods Primers;2024-01-25

5. Clinical pilot study on microfluidic automation of IGH-VJ library preparation for next generation sequencing;Clinical Chemistry and Laboratory Medicine (CCLM);2023-12-29